|
2011
|
Invention
|
Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opio... |
|
|
Invention
|
Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists. Described he... |
|
2010
|
Invention
|
Use of cannabidiol prodrugs in topical and transdermal administration with microneedles. Describe... |
|
|
Invention
|
Formulations of cannabidiol and methods of using the same. Described herein are pharmaceutical co... |
|
2009
|
Invention
|
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagonists. Described he... |
|
2008
|
Invention
|
Methods and compositons for enhancing the viability of microneedle pores. Described herein is a m... |
|
|
Invention
|
Methods and compositions for enhancing the viability of microneedle pores. Described herein is a ... |
|
|
Invention
|
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and me... |
|
|
Invention
|
Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the... |
|
2007
|
Invention
|
Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof. Descri... |
